ESMO Congress 2023 Virtual Platform

(38)

Department of oncology - Esmo Congress TV

(6:29)

ESMO 2022 Highlights

(1:)

ESMO Congress 2021: Prof. Solange Peters on what is special about the congress

(56)

ESMO Congress 2024 GU Round-Up: Prostate Cancer

(6:30)

Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC

(7:)

Expert Commentary: Developmental therapeutics at ESMO Congress 2021

(10:19)

Oncology Part-1

(1:4:26)

6th Annual Congress of SLCTRIMS (2025) - Day 1

(6:13:32)

CLINIC NURSE VS. HOSPITAL NURSE

(8:47)

ESMO 2024: Highlights and analysis

(24:35)

Live: Houston ISD Superintendent Mike Miles announces National Assessment results

(10:21)

OncLive News Network On Location: ESMO 2019 Day 1

(28:47)

Highlights on sotorasib plus panitumumab in KRAS G12C-mutated mCRC: The CodeBreak 300 study

(4:9)

Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC

(5:18)

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2

(4:17)

Expert video report on immunotherapy novelties in the management of patients with endometrial cancer

(8:32)

NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer

(2:21)

ESMO Congress 2019 Daily Reporter - Editor's Picks: Prostate cancer

(27)

Expert Commentary: Immunotherapeutics at ESMO Congress 2021

(9:16)

ESMO Congress 2021: Rosa Giuliani - Patient Advocacy Track

(3:30)

ESMO Congress 2023 Patient Advocacy Track Testimonial with André Deschamps

(1:14)

Follow the ESMO Congress 2019 on the new digital Daily Reporter

(30)

Preview: Priority Review in Multiple Myeloma and 2016 ESMO Congress Highlights

(35)

ESMO Congress 2023 Patient Advocacy Track Testimonial with Barbara Moss

(2:15)

ESMO Congress 2023 Patient Advocacy Track Testimonial with Natacha Bolanos

(1:51)

Introduction to ESMO Congress 2017 in Madrid, Spain

(1:33)

ESMO 2024 Conference Wrap-Up with Rebecca Dent, MD, FRCP, Scientific Chair

(6:24)